InsiderTrades

Form 4 for NUVB Nuvation Bio Inc.

Accepted 2025-11-21 00:00:00 ET · period of report 2025-11-19 · accession 0001865826-25-000004 · SEC index · Original document

Summary rows

Aggregated the way they appear in lists: one row per insider, transaction code and security table.

X Filed Traded Ticker Insider Title Type Price Qty Owned ΔOwn Value
D 2025-11-21 2025-11-19 NUVB Hanley David C. CHIEF TECHNICAL Ops M - OptEx $1.87 +200.0K 224.0K +833% +$374.0K
D 2025-11-21 2025-11-19 NUVB Hanley David C. CHIEF TECHNICAL Ops S - Sale+OE $7.14 -200.0K 24.0K -89% -$1.43M
D 2025-11-21 2025-11-19 NUVB Hanley David C. CHIEF TECHNICAL Ops M - OptEx $0.00 -200.0K 300.0K -40% $0

Purchase Sale Sale after option exercise All abbreviations

Every reported transaction

#TableSecurityDateCodeA/DSharesPriceOwned afterOwnExercise / expiryUnderlyingFootnotes
1 Common Class A Common Stock 2025-11-19 M A 200,000 $1.87 224,000 D — — (F1) Includes 3,000 shares acquired on each of May 19, 2025 and November 19, 2025 under the Issuer's 2021 Employee Stock Purchase Plan.
2 Common Class A Common Stock 2025-11-19 S D 200,000 $7.14 24,000 D — — (F2) Price reported is a weighted-average sales price. The shares were sold at prices ranging from $7.045 to $7.260. The Reporting Person will provide upon request to the SEC, the Issuer or security holder of the Issuer, full information regarding the number of shares sold at each separate price.
3 Derivative Stock Option (Right to Buy) 2025-11-19 M D 200,000 $0.00 300,000 D $1.87 · — to 2034-02-27 200,000 Class A Common Stock (F3) Option vests as to 25% on the one year anniversary of 2/29/2024, and monthly thereafter over the following 36 months, subject to Reporting Person's continuous service on each such vesting date.